Tag: MISSION

WEXFORD, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, is pleased to announce the extinguishment of its convertible note with YA II PN, Ltd (“Yorkville”).  

Ningbo, China, July 22, 2025 (GLOBE NEWSWIRE) -- Skycorp Solar Group Limited (the “Company”) (NASDAQ: PN), a solar PV product provider engaged in the manufacture and sale of solar cables and solar connectors, today announced the adoption of cryptocurrency as an accepted method of payment for international transactions, effective August 1, 2025. The Company will support leading digital assets, including Bitcoin (BTC), Ethereum (ETH), and major stablecoins such as USDC and USDT.

DUBLIN, Ireland, July 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a provider of integrated energy solutions, today announced that Bright Hydrogen Solutions Ltd (“BrightHy Solutions”), a Fusion Fuel subsidiary and provider of hydrogen solutions, executed a non-binding Term Sheet (the “Term Sheet”) outlining the terms of a strategic partnership focused on investments in hydrogen projects and infrastructure with an integrated green energy technologies provider (the “Partner”). As contemplated by the Term Sheet, subject to execution of one or more binding agreements, the Partner would commit up to €30 million in capital over four years to be invested in certain hydrogen projects. These investments are expected to be channeled through special purpose vehicles held by a newly created investment entity to be majority-owned by the Partner.

SHANGHAI, July 22, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX”), a global mobility technology provider, today announced it has signed a strategic cooperation agreement with Monolithic Power Systems, Inc. ("MPS") (Nasdaq: MPWR), a fablite global company that provides high-performance, semiconductor-based power electronics solutions. The partnership will focus on collaboration in automotive intelligence and robotics and AI applications to establish a global supply chain and intelligent industrial ecosystem spanning system integration, platform adaptation, and delivery.

CTO, CMO and CFO appointments to advance the commercial launch of its precision point-of-care diagnostic Lodestar DX for UTIs worldwide

Datavault AI Selected to Support Mission-Critical Defense and Aerospace Programs in Strategic Partnership with Burke Engineering

COPENHAGEN, Denmark, July 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Health Canada has accepted for review the Company’s application for licensure of the single-dose, virus-like particle (VLP) chikungunya vaccine candidate, CHIKV VLP, for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older. The application screening acceptance by the Directorate confirms that the New Drug Submission is complete and begins a standard review procedure, potentially supporting approval of the vaccine in the first half of 2026.

KØBENHAVN, Danmark, 22. juli 2025 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag, at de canadiske lægemiddelmyndigheder, Health Canada, har accepteret selskabets ansøgning om markedsføringstilladelse for den virus-lignende partikel (VLP)-baserede, enkelt-dosis chikungunyavaccinekandidat, CHIKV VLP, til forebyggelse af sygdom forårsaget af chikungunyavirus hos personer på 12 år og ældre. Dermed starter myndighedernes standardgennemgang, hvilket potentielt understøtter godkendelse af vaccinen i første halvår 2026.